GSK Is Now Favorite to Acquire Pfizer's Consumer Health Business By Sam | March 21, 2018 Now that Reckitt Benckiser has walked away from a deal, GlaxoSmithKline is now the favorite to acquire Pfizer’s consumer health business. Source: BioSpace Posted in BioPharma